The results of a study by Kadish et al.15revealed that in patients with severe nonischemic DCM who underwent ICD with ACE inhibitors and β‐blockers, the risk of SCD were significantly lower than those who received conventional therapy with only medical treatments. Here, ACE is linked to familial dilated cardiomyopathy.